Patel C, Sheth V, Koppula R, Kumar A, et al. Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometa Respir Med 2025;247:108293.
PMID: 40759266